ENDO5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | ||
__TOC__ | __TOC__ | ||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
| Line 18: | Line 19: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
|CHAPTER 2 (PITUITARY TUMOURS) | | | ||
==== CHAPTER 2 (PITUITARY TUMOURS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 280: | Line 282: | ||
| | | | ||
|- | |- | ||
|CHAPTER 3 (THYROID TUMOURS) | | | ||
==== CHAPTER 3 (THYROID TUMOURS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 575: | Line 578: | ||
| | | | ||
|- | |- | ||
|CHAPTER 4 (PARATHYROID TUMOURS) | | | ||
==== CHAPTER 4 (PARATHYROID TUMOURS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 650: | Line 654: | ||
| | | | ||
|- | |- | ||
|CHAPTER 5 (ADRENAL GLAND TUMOURS) | | | ||
==== CHAPTER 5 (ADRENAL GLAND TUMOURS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 780: | Line 785: | ||
| | | | ||
|- | |- | ||
|CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS) | | | ||
==== CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 888: | Line 894: | ||
| | | | ||
|- | |- | ||
|CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS) | | | ||
==== CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,029: | Line 1,036: | ||
| | | | ||
|- | |- | ||
|CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS) | | | ||
==== CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,126: | Line 1,134: | ||
| | | | ||
|- | |- | ||
|CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS) | | | ||
==== CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,289: | Line 1,298: | ||
| | | | ||
|- | |- | ||
|CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) | | | ||
==== CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,386: | Line 1,396: | ||
| | | | ||
|- | |- | ||
|CHAPTER 11 (GERM CELL TUMOURS) | | | ||
==== CHAPTER 11 (GERM CELL TUMOURS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,428: | Line 1,439: | ||
| | | | ||
|- | |- | ||
|CHAPTER 12 (METASTASIS) | | | ||
==== CHAPTER 12 (METASTASIS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,481: | Line 1,493: | ||
| | | | ||
|- | |- | ||
|CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS) | | | ||
==== CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS) ==== | |||
| | | | ||
---- | ---- | ||